BioFinance 2008 Toronto Marriott Eaton Centre Hotel -  Toronto May 7, 2008 at 9:00 a.m. EDT Presenter: Donald F. Corcoran, President & CEO ASCO 2008 Annual Meeting May 31 to June 3, 2008 - Chicago Publication: Molecular Cancer Therapeutics MGCD0103, a novel isotype-selective HDAC inhibitor, has broad spectrum antitumor activity in vitro and in vivo April 2008, Vol. 7, No. 4: 759-768. Publication: Bioorganic & Medicinal Chemistry Letters Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases 18 (April 2008) 2793-2798.

Our Stock Symbol: MYG.TO Last price: 2.50 Volume 0 Open: 2.49 High: 2.50 Low: 2.49 52 Week Range: 1.82 - 4.95